Moderna just had its best day since October. Here's what's going on, and what analysts expect
Analysts pointed to an upcoming health care conference and cancer data study release as potential catalysts for Moderna's ongoing rally.
Last updated: 2026-01-08 03:47:48 ET
Analysts pointed to an upcoming health care conference and cancer data study release as potential catalysts for Moderna's ongoing rally.
MSCI announced it will keep digital asset treasury companies in its global indexes, citing investor feedback and the need for further study on non-ope...
New research recommends against drinking coffee or tea served by airlines, urging travelers to stick to bottled water.
Updated feasibility study outlines funding plans, production timelines and long-term value from the Botswana mine underground expansion.
A new study from researchers at Stanford University and Nvidia proposes a way for AI models to keep learning after deployment — without increasing i...
A new study found that the court’s Republican appointees voted for the wealthier side in cases 70 percent of the time in 2022, up from 45 percent in...
Descriptive set theorists study the niche mathematics of infinity. Now, they’ve shown that their problems can be rewritten in the concrete language ...
Problems with a 25-year-old landmark paper on the safety of Roundup’s active ingredient, glyphosate, have led to calls for the E.P.A. to reassess th...
Large language models repeatedly chased losses, escalated risk and even bankrupted themselves in simulated gambling environments, a study found.